119 related articles for article (PubMed ID: 23074147)
1. Cytotoxic action of Brazilian propolis in vitro on canine osteosarcoma cells.
Cinegaglia NC; Bersano PR; Búfalo MC; Sforcin JM
Phytother Res; 2013 Sep; 27(9):1277-81. PubMed ID: 23074147
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effects of geopropolis produced by stingless bees on canine osteosarcoma cells in vitro.
Cinegaglia NC; Bersano PR; Araújo MJ; Búfalo MC; Sforcin JM
Evid Based Complement Alternat Med; 2013; 2013():737386. PubMed ID: 23690851
[TBL] [Abstract][Full Text] [Related]
3. Positive effects of antitumor drugs in combination with propolis on canine osteosarcoma cells (spOS-2) and mesenchymal stem cells.
Bernardino PN; Bersano PRO; Lima Neto JF; Sforcin JM
Biomed Pharmacother; 2018 Aug; 104():268-274. PubMed ID: 29775894
[TBL] [Abstract][Full Text] [Related]
4. The chemical composition and events related to the cytotoxic effects of propolis on osteosarcoma cells: A comparative assessment of Colombian samples.
Mora DPP; Santiago KB; Conti BJ; de Oliveira Cardoso E; Conte FL; Oliveira LPG; de Assis Golim M; Uribe JFC; Gutiérrez RM; Buitrago MR; Popova M; Trusheva B; Bankova V; García OT; Sforcin JM
Phytother Res; 2019 Mar; 33(3):591-601. PubMed ID: 30488503
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapy.
Inkol JM; Poon AC; Mutsaers AJ
Vet Comp Oncol; 2020 Dec; 18(4):559-569. PubMed ID: 32060984
[TBL] [Abstract][Full Text] [Related]
6. BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance.
Shahi MH; York D; Gandour-Edwards R; Withers SS; Holt R; Rebhun RB
PLoS One; 2015; 10(6):e0131006. PubMed ID: 26110620
[TBL] [Abstract][Full Text] [Related]
7. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF
J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
McMahon MB; Bear MD; Kulp SK; Pennell ML; London CA
Am J Vet Res; 2010 Jul; 71(7):799-808. PubMed ID: 20594083
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy of canine osteosarcoma with canine bone marrow stem cells, bone morphogenetic protein and carboplatin in an in vivo model.
Rici REG; Will SEAL; Luna ACL; Melo LF; Santos AC; Rodrigues RF; Leandro RM; Maria DA
Vet Comp Oncol; 2018 Dec; 16(4):478-488. PubMed ID: 29781255
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells.
Fahey CE; Milner RJ; Kow K; Bacon NJ; Salute ME
Anticancer Drugs; 2013 Jun; 24(5):519-26. PubMed ID: 23466652
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype.
Jackson M; Serada N; Sheehan M; Srinivasan S; Mason N; Guha M; Avadhani N
PLoS One; 2018; 13(12):e0209489. PubMed ID: 30576337
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory Effects of a Reengineered Anthrax Toxin on Canine and Human Osteosarcoma Cells.
Mackowiak da Fonseca J; Mackowiak da Fonseca II; Nagamine MK; Massoco CO; Nishiya AT; Ward JM; Liu S; Leppla SH; Bugge TH; Dagli MLZ
Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32987941
[TBL] [Abstract][Full Text] [Related]
13. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
14. The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells in vitro.
Farese JP; Ashton J; Milner R; Ambrose LL; Van Gilder J
In Vitro Cell Dev Biol Anim; 2004; 40(3-4):113-7. PubMed ID: 15311969
[TBL] [Abstract][Full Text] [Related]
15. Investigating CXCR4 expression in canine appendicular osteosarcoma.
Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
[TBL] [Abstract][Full Text] [Related]
16. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
[TBL] [Abstract][Full Text] [Related]
17. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.
Morello E; Martano M; Buracco P
Vet J; 2011 Sep; 189(3):268-77. PubMed ID: 20889358
[TBL] [Abstract][Full Text] [Related]
18. Chemical and cytotoxic analyses of brown Brazilian propolis (Apis mellifera) and its in vitro activity against itraconazole-resistant Sporothrix brasiliensis.
Waller SB; Peter CM; Hoffmann JF; Picoli T; Osório LD; Chaves F; Zani JL; de Faria RO; de Mello JR; Meireles MC
Microb Pathog; 2017 Apr; 105():117-121. PubMed ID: 28219829
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cells.
Kurzman ID; Shi F; Vail DM; MacEwen EG
Cancer Biother Radiopharm; 1999 Apr; 14(2):121-8. PubMed ID: 10850295
[TBL] [Abstract][Full Text] [Related]
20. Investigating TrkA expression in canine appendicular osteosarcoma.
Fan TM; Barger AM; Sprandel IT; Fredrickson RL
J Vet Intern Med; 2008; 22(5):1181-8. PubMed ID: 18638015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]